Adafenoxate

This classification denotes an antidepressant agent with the molecular formula C20H26ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B8VQU4C05J, chemically known as 2-(1-tricyclo(3.3.1.1(3,7))decylamino)ethyl (4-chlorphenoxy)acetat but generally known as adafenoxate, which bears US NIH Compound Identifier 64517. European Medicines Agency schedules Adafenoxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05259MIG. The term ADAFENOXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). ADAFENOXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule adafenoxate under HS 29221980 and SITC 51461. As of Q4 2014, ADAFENOXATE remains the US FDA Preferred Term for this commodity. Adafenoxate bears US NLM identifiers UMLS ID C0050721 and NCI Concept Code C72680. SMILES: Clc1ccc(OCC(=O)OCCNC23CC4CC(C3)CC(C2)C4)cc1.